{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:13:03Z","timestamp":1781305983081,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-CoV19-001"],"award-info":[{"award-number":["2022-I2M-CoV19-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bmcl.2025.130293","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:26:19Z","timestamp":1748949979000},"page":"130293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of 3-phenyl-1H-5-pyrazolylamides as PLpro inhibitors through virtual screening and structure optimization"],"prefix":"10.1016","volume":"127","author":[{"given":"Chengwei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130293_bb0005","author":"WHO COVID-19 dashboard"},{"key":"10.1016\/j.bmcl.2025.130293_bb0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130293_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq7360","article-title":"SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376","volume":"15","author":"Heilmann","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2025.130293_bb0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41551-020-00658-w","article-title":"Development of vaccines and antivirals for combating viral pandemics","volume":"4","author":"Pardi","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.bmcl.2025.130293_bb0025","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acsptsci.3c00134","article-title":"Deuremidevir and Simnotrelvir-ritonavir for the treatment of COVID-19","volume":"6","author":"Zhu","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bmcl.2025.130293_bb0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2208822","article-title":"VV116 versus Nirmatrelvir-ritonavir for oral treatment of covid-19","volume":"388","author":"Cao","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130293_bb0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa2301425","article-title":"Oral Simnotrelvir for adult patients with mild-to-moderate covid-19","volume":"390","author":"Cao","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130293_bb0040","doi-asserted-by":"crossref","first-page":"35500","DOI":"10.1039\/D3RA06479D","article-title":"Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2","volume":"13","author":"Yevsieieva","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2025.130293_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmcl.2025.130293_bb0050","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/v14091991","article-title":"SARS-CoV-2 non-structural proteins and their roles in host immune evasion","volume":"14","author":"Low","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2025.130293_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcdb.2022.06.005","article-title":"Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free interferon stimulated gene product-15 (ISG15)","volume":"132","author":"Gold","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.bmcl.2025.130293_bb0060","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2025.130293_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2025.130293_bb0070","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0075","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2025.130293_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1067408","article-title":"In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542","volume":"14","author":"Cho","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130293_bb0085","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity","volume":"65","author":"Shen","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/acs.chemrestox.7b00083","article-title":"Evaluation of different methods for identification of structural alerts using chemical Ames mutagenicity data set as a benchmark","volume":"30","author":"Yang","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmcl.2025.130293_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2018.10.018","article-title":"Naphthalene, a versatile platform in medicinal chemistry: sky-high perspective","volume":"161","author":"Makar","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114572","article-title":"Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV\/SARS-CoV-2 papain-like protease inhibitors","volume":"240","author":"Valipour","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado4288","article-title":"Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model","volume":"10","author":"Garnsey","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmcl.2025.130293_bb0110","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1021\/acs.jmedchem.4c00534","article-title":"Design, synthesis, and biological evaluation of 1,2,4-oxadiazole derivatives containing an aryl carboxylic acid moiety as potent Sarbecovirus papain-like protease inhibitors","volume":"67","author":"Qin","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0115","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1038\/s41467-024-54462-0","article-title":"Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19","volume":"15","author":"Lu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130293_bb0120","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/s41467-025-57905-4","article-title":"A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID","volume":"16","author":"Bader","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130293_bb0125","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.bmc.2011.06.016","article-title":"Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)","volume":"19","author":"Lin","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmcl.2025.130293_bb0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bioorg.2018.11.029","article-title":"Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors","volume":"84","author":"Petek","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1573406411666141210141317","article-title":"Synthesis and biological evaluation of pyrazolo[3,4-b]pyridin-4-ones as a new class of topoisomerase II inhibitors","volume":"11","author":"Tabrizi","year":"2015","journal-title":"Med Chem"},{"key":"10.1016\/j.bmcl.2025.130293_bb0145","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:21:03Z","timestamp":1752600063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"alternative-id":["S0960894X25002021"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130293","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 3-phenyl-1H-5-pyrazolylamides as PLpro inhibitors through virtual screening and structure optimization","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130293"}}